Market News

KKR Founder Jerome Kohlberg Dies

Related Link: 

Jerome Kohlberg, a co-founder of private-equity giant KKR & Co. and an architect of the industry’s leveraged-buyout model, has died. He was 90.

'Therapeutic' Approach to Financial Planning

Related Link: 

Financial planners are borrowing techniques from psychologists to help clients get in touch with the often messy feelings behind their relationships with money.

Carlyle Fund Walloped in Commodities Rout

Related Link: 

A rout in raw materials has helped drive down holdings in a Carlye Group firm’s flagship fund from about $2 billion to less than $50 million. The collapsing commodities market is spreading pain well beyond specialists to some of the heaviest hitters on Wall Street.

Police Arrest Ex-Head of Bitcoin Exchange Mt. Gox

Related Link: 

Japanese police arrested Mark Karpelès, the head of collapsed bitcoin exchange Mt. Gox, alleging that he manipulated the company’s computer system to increase the balance in an account.

Riots to Riches: China's Wild Market Swings

Related Link: 

After nearly 25 years of turbulent action that has elated and infuriated investors, China’s stock markets remain much as they were when they opened in 1990. Beijing calls the shots.

Commodities Slide Deeper Into a Rut

Related Link: 

Commodity prices tumbled anew, plunging the S&P GSCI Total Return index to its worst monthly loss since November 2008 and deepening a yearslong rout that few observers expect to moderate.

As Fed Move Nears, Traders Obsess Over Data

Related Link: 

Traders are scouring once-overlooked economic data for clues to the timing of the Federal Reserve’s first interest rate rise in years.

Athens Is Lifting Stock-Trading Halt

Related Link: 

Trading in Greek stocks will resume Monday on the Athex exchange, ending a more than monthlong closure during which the country struggled to avoid an exit from the eurozone.

U.S. Labor Costs Rise at Slowest Pace in Three Decades

Related Link: 

U.S. labor costs rose at the slowest pace in at least three decades in the spring, a sign of persistently sluggish wage growth that could weigh on the Federal Reserve’s decision to raise short-term interest rates.

Amgen to Undergo Experimental Treatment

Related Link: 

Amgen shareholders should be watching the development of U.S. biosimilars carefully.

Syndicate content